ArticleInternational journal of clinical and experimental pathology2017
Gene silencing NMII promotes axonal regeneration against contusive spinal cord injury in rats.
Article in International journal of clinical and experimental pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
- Article
- The potential of gene therapies for spinal cord injury repair: a systematic review and meta-analysis of pre-clinical studies.Neural regeneration research · 2023Article
- Review
Corrections and comments
- Erratum issued
Authors and funding
7 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There are drastic changes that occur in the impaired regions after spinal cord injury (SCI), however, improvement of the detrimental pathological process after injury is limited in the mammalian adult, which is due a large part to the failure of local axons to grow. Non-muscle myosin II (NMII) has been proved having essential role in the regulation of cytoskeletal structure and genetic silencing NMII markedly accelerates axon growth in vitro. Our purpose is to explore the association between phosphorylated NMII expression and axonal regeneration after SCI in rats and determine whether gene silencing NMII can improve the locomotor function in rats with SCI. The results showed that phosphorylated NMII level was up regulated after SCI and may even play important role in inhibiting neuronal survival and axonal regeneration. After silencing NMII, the viability of neurons, proliferation of axons, synaptic connection and locomotor functional recovery were promoted significantly after SCI. Our study provides an effective way by direct regulation of neuron viability, the proliferation of axons and synaptic connection for treating SCI, which may be a novel method for repairing SCI. However, the specific signaling pathway mechanisms about the recovery require further study.
Indexed as
Identifiers
31966489PMC6965883W3026888862What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.